7 research outputs found
Amniotic membrane extract cytotoxicity measurement using real-time cell analysis.
<p>Each result was presented as mean from 5 independent experiment with SD bars. No statistically significant differences in cell viability were observed between AME treated and control cells (p>0.05) after 72 hours.</p
The mechanical evaluation of reconstructed bladder wall based on Youngâs elastic modulus.
<p>Youngâs modulus of intact and reconstructed bladder walls were compared to the digitally estimated content of smooth muscle content based on TRI staining average. Additionally, to reflect changes in the remodeling of the augmented bladder wall, Youngâs modulus of Am and PLCL are presented. The presented values of smooth muscle content was rounded up.</p
Percentage of the reconstructed bladder wall covered with smooth muscle.
<p>Staining with (A) TRI and (B) anti-smoothelin staining. The regenerated bladder wall with a statistically similar (TRI [p = 0.03] and anti-smoothelin staining [p = 0.35]) smooth muscle content compared to the bladder wall in the control group (*).</p
Preparation and structure of biocomposite.
<p>(A) The pieces of Am (black arrows) placed onto a sheet of PLCL nanofibers. A drum is used as a target during the nanofiber production process. SEM images are displayed in B-D. (B) A cross-section image of the biocomposite material. The biocomposite material is 389 um thick with an inner cavity containing the Am. (C) Visible drops of glycerin used for Am preservation are observed on surface of PLCL nanofibers (white arrows). (D) Two pieces of delaminated biocomposite material. The borders between consecutive sheets of nanofibers (*) are clearly visible with Am inside.</p
Urinary bladder augmented with biocomposite.
<p>(A) Biocomposite material scaffold prepared for the suture procedure. (B) Urinary bladder after the augmentation procedure. Single fixing sutures are visible (black arrows). The optimal compliance of the biocomposite material scaffold allowed for bladder filling shortly after the surgical procedure. (C) Resected reconstructed bladder 3 months after augmentation. The regenerated bladder wall (blue and cyan line was well integrated with the native bladder wall (black line). The borderline between the intact part of the bladder and the reconstructed one was indistinct and without scar formation (blue line). The upper surface of regenerated bladder wall (cyan line) was covered with adipose tissue forming a vascular pedicle (red line) derived from the omentum majus (green line). The bladder neck (yellow line) can be observed with adjacent fragments of seminal vesicles (white line).</p
Histological and immunohistological analysis of the reconstructed urinary bladder wall.
<p>Am; Amniotic membrane, Ur; Urothelium, Bl; lumen of urinary bladder, IBW; Intact host urinary bladder wall. (A) H&E staining displaying mild inflammatory infiltration. (B) TRI displaying regenerating single muscle bundles from the central part of the reconstructed bladder wall. (C) Anti-smoothelin staining revealing frequently arranged smooth muscle bundles. Strong immunoreactivity beneath the urothelium layer is observed. (D) H&E staining revealing the border between the intact bladder wall and reconstructed bladder wall (zigzag line). The elongating smooth muscle cells (black arrows) gradually loose their layered architecture. Moderate inflammatory infiltration is also observed. (E) TRI displaying the regularly arranged smooth muscle bundles; some smooth muscle bundles run transversely (cyan line), but the most obvious bundles run longitudinally (black line). The specimen was obtained from the edge of the reconstructed bladder wall. (F) Anti-smoothelin staining displaying the distribution of smoothelin positive-cells (black ovals) under the urothelial layer. (G) TRI staining displaying the abundant disorganised hypertrophied smooth muscle bundles in the peripheral part of the reconstructed bladder wall. (H) TRI showing smooth muscle bundles separated by collagenous fibres in the central part of the reconstructed bladder wall. (I) Anti-smoothelin staining revealing abundant smoothelin expression in the peripheral part of the reconstructed bladder wall.</p
Amniotic membrane extract cytotoxicity measurement using the MTT assay.
<p>Each result was presented as an average from 5 independent experiment with SD bars. No statistically significant difference in cell viability was observed between AME treated and control cells (p>0.05) after 24 hours.</p